台股 » 個股 » 台新藥 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

台新藥

(6838)
  • 股價
    39.65
  • 漲跌
    ▼0.25
  • 漲幅
    -0.63%
  • 成交量
    221
  • 產業
    上市 生技醫療類股
  • 21人加入追蹤

    立即追蹤

  • 本地時間:13:30(已收盤)

     
台新藥 (6838)籌碼相關-美林 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

美林 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2024/11/18540.107039.8339.90-65813-7.99%
2024/11/15442.01442.1841.7008150.00%
2024/11/1400.001042.5241.25-10824-1.21%
2024/11/131142.67242.6042.6098341.08%
2024/11/1200.002043.1942.70-20876-2.28%
2024/11/1100.00544.2243.60-5967-0.52%
2024/11/0800.00144.3544.40-1973-0.10%
2024/11/07444.38444.3344.3509770.00%
2024/11/063045.185545.1944.35-25980-2.55%
2024/11/051247.002646.5346.55-14978-1.43%
2024/11/047046.315845.8845.80129721.23%
2024/11/015744.502144.4245.30369663.73%
2024/10/29144.005243.3942.60-51968-5.27%
2024/10/28344.384344.7544.05-40965-4.14%
2024/10/252044.85844.2845.10129751.23%
2024/10/242744.7200.0044.00279732.77%
2024/10/231743.8000.0044.00179771.74%
2024/10/2200.004943.7043.75-49981-4.99%
2024/10/213844.60244.7344.30369833.66%
2024/10/181344.052244.3844.10-9986-0.91%
2024/10/171544.97144.4044.50149931.41%
2024/10/161444.521044.5444.5049970.40%
2024/10/153743.7300.0043.55371,0083.67%
2024/10/14245.252145.5044.75-191,001-1.90%
2024/10/113145.993045.8745.7519990.10%
2024/10/0900.002646.3346.00-26991-2.62%
2024/10/082246.0416046.6046.35-138985-14.00% 大賣/鉅額交易
2024/10/0711648.402548.1348.25919709.38% 大買/
2024/10/0417748.896948.6648.6510895611.29% 大買/鉅額交易
2024/10/016349.341350.0749.25509355.34%
2024/09/305846.394347.5048.25158801.70%
2024/09/271943.8800.0043.90198382.27%
2024/09/2600.00143.5542.75-1835-0.12%
2024/09/2500.00244.2543.15-2835-0.24%
2024/09/2400.00644.6343.50-6841-0.71%
2024/09/23944.591544.2344.45-6830-0.72%
2024/09/203544.701344.8444.60228222.67%
2024/09/191745.161645.2944.9018170.12%
2024/09/181244.333244.8643.95-20802-2.49%
2024/09/164045.206445.0944.65-24798-3.00%
2024/09/136445.23745.9046.05577787.32%
2024/09/122141.9500.0041.90217362.85%
2024/09/11242.50543.5042.50-3723-0.41%
2024/09/10644.751046.4645.50-4694-0.58%
2024/09/091042.704240.9043.75-32635-5.03%
2024/09/064139.4900.0039.80415906.94%
2024/09/0400.00338.0537.25-3579-0.52%
2024/09/0300.00838.7338.55-8573-1.39%
2024/09/0200.003439.2438.90-34574-5.92%
2024/08/30739.86139.9539.9565711.05%
2024/08/29539.3700.0039.5055690.88%
2024/08/28838.8600.0038.9085641.42%
2024/08/2700.00638.8538.65-6558-1.07%
2024/08/26339.0500.0038.9035520.54%
2024/08/2300.002339.0239.00-23547-4.20%
2024/08/223239.8100.0039.50325415.91%
2024/08/21539.5500.0039.2055340.94%
2024/08/201739.9900.0039.20175293.21%
2024/08/1900.00239.3339.00-2510-0.39%
2024/08/16139.7000.0039.6514980.20%
2024/08/1500.00139.9039.90-1489-0.20%
2024/08/14239.5500.0039.5524770.42%
〈焦點股〉台新藥眼科新藥出貨至美國展望正向 觸及漲停Anue鉅亨-2024/09/13
〈焦點股〉台新藥眼科新藥9月正式外銷至美國 漲逾半根停板Anue鉅亨-2024/09/06
台新藥 相關文章
台新藥 相關影音